Rapid Micro Biosystems, Inc. (RPID) Revenue History
Annual and quarterly revenue from 2019 to present
RPID Revenue Over Time (2019–2025)
RPID Revenue Growth History
4 of 6 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- -2.6%
- FY2021 revenue growth
- +44.5%
- FY2022 revenue growth
- -26.3%
- FY2023 revenue growth
- +31.4%
- FY2024 revenue growth
- +24.6%
- FY2025 revenue growth
- +19.7%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $8.0M | +11.1% |
| Q4 2025 | $11.3M | +37.3% |
| Q3 2025 | $7.8M | +3.1% |
| Q2 2025 | $7.3M | +9.7% |
| Q1 2025 | $7.2M | +28.4% |
| Q4 2024 | $8.2M | +29.7% |
| Q3 2024 | $7.6M | +23.7% |
| Q2 2024 | $6.6M | +32.3% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
RPID's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
RPID Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 22, 2026, Rapid Micro Biosystems, Inc. (RPID) generated trailing twelve-month (TTM) revenue of $34.4 million, reflecting strong growth of +11.1% year-over-year. The most recent quarter (Q1 2026) recorded $8.0 million in revenue, down 29.1% sequentially.
Historical Growth Trajectory
RPID's 5-year compound annual growth rate (CAGR) stands at +15.9%, indicating consistent double-digit revenue growth. The 3-year CAGR of +25.2% exceeds the 5-year average, indicating an acceleration in the most recent period. Rapid Micro Biosystems, Inc.'s highest annual revenue of $33.6 million was recorded in 2025, an all-time high.
Revenue by Segment
RPID's revenue is primarily driven by Product (72%), and Service (28%). With over half of revenue concentrated in Product, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including IDXX (+13.1% YoY), NEOG (-3.7% YoY), and BRKR (+0.4% YoY) — RPID has outperformed the peer group in revenue growth. Compare RPID vs IDXX →
RPID Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RPIDCurrent | $34M | +11.1% | +15.9% | -141.1% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% | |
 NEOG | $895M | -3.7% | +16.4% | 1.1% | |
 BRKR | $3.4B | +0.4% | +11.6% | 6.9% | |
 AZTA | $594M | +1.8% | +8.9% | -1.9% | |
 BIO | $2.6B | +1.9% | +0.3% | 10.5% |
RPID Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $33.6M | +19.7% | $7.6M | 22.7% | $-47,392,000 | -141.1% |
| 2024 | $28.1M | +24.6% | $-109,000 | -0.4% | $-49,919,000 | -178.0% |
| 2023 | $22.5M | +31.4% | $-5,485,000 | -24.4% | $-56,563,000 | -251.2% |
| 2022 | $17.1M | -26.3% | $-8,540,000 | -49.8% | $-63,219,000 | -369.0% |
| 2021 | $23.2M | +44.5% | $-7,741,000 | -33.3% | $-47,232,000 | -203.3% |
| 2020 | $16.1M | -2.6% | $-8,071,000 | -50.2% | $-30,540,000 | -190.0% |
| 2019 | $16.5M | - | $-234,000 | -1.4% | $-18,634,000 | -112.9% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RPID — Frequently Asked Questions
Quick answers to the most common questions about buying RPID stock.
Is RPID's revenue growth accelerating or slowing?
RPID revenue growth is holding steady at +11.1% year-over-year. TTM revenue is $34M. The current growth rate closely tracks the 5-year CAGR of +15.9%, signalling consistent execution.
What is RPID's revenue history from 2019 to 2026?
Rapid Micro Biosystems, Inc. (RPID) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $34M, growing at +11.1% YoY. The 5-year CAGR is +15.9%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is RPID's long-term revenue growth rate (CAGR)?
Rapid Micro Biosystems, Inc.'s 5-year revenue CAGR of +15.9% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +11.1% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for RPID.
Why does RPID's quarterly revenue fluctuate?
RPID quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Rapid Micro Biosystems, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is RPID's revenue distributed by segment?
RPID reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does RPID's revenue compare to industry peers?
Rapid Micro Biosystems, Inc. (RPID) with TTM revenue of $34M and +11.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.